cholesterol-lowering drugs might increase the risk of cancer
Patients are concerned about recent reports that many cholesterol-lowering drugs might increase the risk of cancer.
This was triggered by an article recently published in JAMA.
The authors suggest limiting the use of "statins" such as lovastatin...and fibrates such as gemfibrozil (Lopid).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote